Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.42%
1,099.43
-4.67
-0.42%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.57%
607.58
+3.42
+0.57%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.34%
1,193.76
-4.05
-0.34%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.24%
1,736.28
-4.13
-0.24%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.66%
638.63
+4.19
+0.66%
—634.44633.13639.67633.01——
SIXR
Staples
SIXR
Staples
SIXR
-0.72%
834.84
-6.06
-0.72%
—840.90839.53841.73834.47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.39%
214.29
-0.84
-0.39%
—215.13215.13215.85213.99——
SIXT
Technology
SIXT
Technology
SIXT
-0.36%
3,217.23
-11.42
-0.36%
—3,228.713,225.623,227.743,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.19%
937.67
+1.80
+0.19%
—935.87938.37942.00936.95——
SIXV
Health care
SIXV
Health care
SIXV
-0.15%
1,454.99
-2.13
-0.15%
—1,457.121,452.741,466.881,449.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.51%
2,387.54
-12.30
-0.51%
—2,399.842,389.712,392.302,371.22——
CRSP:NASDAQ
Crispr Therapeutics AG
$51.27
+5.09%
(+2.48) 1D
Apr 27, 1:06:43 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRSP...
Open
$50.59
High
$54.04
Low
$50.50
Mkt. cap
4.94B
Avg. vol.
2.13M
Volume
1.79M
52-wk high
$78.48
52-wk low
$33.03
EPS
-$6.47
Beta
1.32
Shares outstanding
96.39M
No. of employees
393
News stories
From sources across the web
Profile
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
About Crispr Therapeutics AG
CEOSamarth Kulkarni
Employees393
Founded2013
HeadquartersZug, Zug, Switzerland
SectorBiotechnology
Websitecrisprtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
865.00K
892.00K
889.00K
864.00K
Cost of goods sold
129.99M
115.05M
116.02M
137.23M
Cost of revenue
129.99M
115.05M
116.02M
137.23M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.30M
18.92M
16.93M
18.40M
Operating expense
19.30M
18.92M
16.93M
18.40M
Total operating expenses
149.29M
133.96M
132.95M
155.63M
Operating income
-148.42M
-133.07M
-132.06M
-154.76M
Other non operating income
13.54M
22.07M
26.24M
24.76M
EBT including unusual items
-134.89M
-207.26M
-105.82M
-130.00M
EBT excluding unusual items
-134.89M
-111.00M
-105.82M
-130.00M
Income tax expense
1.11M
1.29M
619.00K
614.00K
Effective tax rate
-0.82%
-0.62%
-0.58%
-0.47%
Other operating expenses
-
-
-
-
Net income
-136.00M
-208.55M
-106.44M
-130.61M
Net profit margin
-15,722.08%
-23,379.93%
-11,973.12%
-15,117.25%
Earnings per share
-1.58
-1.29
-1.17
-1.37
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-143.69M
-128.42M
-127.63M
-149.10M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer